十一月 2025
- Home
- Frontage Laboratories, Inc
十一月 2025的Frontage Laboratories, Inc市场份额分析
Frontage Laboratories is a global pharmaceutical development organization (PDO) advancing drug discovery and development through integrated laboratory and clinical services.
Frontage Laboratories, Inc(包含公司地区分支机构)
查看更多网站流量和参与度信息- frontagelab.com
Frontage Laboratories, Inc收入截至 十一月 2025为 200M - 500M
Frontage Laboratories, Inc主要域名产生的收入
3 年中Frontage Laboratories, Inc主要域名的收入
Frontage Laboratories, Inc主要域名的收入
Frontage Laboratories, Inc热门域名的总访问量
了解Frontage Laboratories, Inc市场份额和潜在市场覆盖范围。
过去 3 个月的总访问量
子公司明细
Frontage Laboratories, Inc热门域名的平均访问时长
分析Frontage Laboratories, Inc参与度指标。
过去 3 个月的平均访问时长
子公司明细
Frontage Laboratories, Inc热门域名的平均页面浏览量
了解Frontage Laboratories, Inc如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。
过去 3 个月的平均页面浏览量
子公司明细
想要获取更深入的流量洞见?
过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。
Frontage Laboratories, Inc 的新闻与信号
借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。
新闻Frontage Laboratories, Inc. acquired Nucro-Technics Inc. on Aug 16th '23.EXTON, Pa. , Aug. 16, 2023 /PRNewswire/ -- Frontage Laboratories, Inc. and its wholly-owned subsidiary, Frontage Canada, Inc., completed the acquisition of Nucro-Technics Inc. and its affiliate Nucro-Technics Holdings, Inc.
八月 16, 2023阅读更多
新闻Frontage Laboratories, Inc. partners with DEA.As part of the settlement, Frontage has entered into a two-year extension of its Memorandum of Agreement (MOA) with the Drug Enforcement Administration (DEA), which includes additional responsibilities regarding the handling of controlled substances.
三月 17, 2023阅读更多
新闻Frontage Laboratories, Inc. promotes John Lin to President.Dr. John Lin has been promoted to President of Frontage Laboratories, Inc., the company's wholly-owned subsidiary.
一月 3, 2023阅读更多
查看 Frontage Laboratories, Inc 的所有信号
让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。